Subtype 1 is an IgG4-associated systemic disorder with pancreatic involvement; it is more common in men, especially older men. [14] The symptoms are nonspecific and include mild epigastric abdominal ...
Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of ...
In a recent study posted to bioRxiv* preprint server, researchers in Germany assessed the differences in antigen-specific immunoglobulin G (IgG) subtypes between post-COVID syndrome (PCS) patients and ...
WASHINGTON — The B-cell depleting agent inebilizumab (Uplizna) dramatically reduced the risk of flares and increased year-long remission of IgG4-related disease (RD), new research has found. The ...
Amgen has bagged a second indication for its B cell-depleting therapy Uplizna after the FDA cleared it for rare inflammatory disease IgG4-related disease (IgG4-RD). Acquired as part of its $27.8 ...
Cholangiographic classification of IgG4-SC into 4 types based on stricture location is crucial to differentiate IgG4-SC from other biliary conditions. Characteristic findings on intraductal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results